Αποτελέσματα Αναζήτησης
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
23 Αυγ 2023 · While several new antiretroviral drugs have been added to the treatment arsenal since 2010, older ones like Crixivan (indinavir), Rescriptor (delavirdine), Videx (didanosine), Viracept (nelfinavir), and Zerit (stavudine) have been discontinued and are no longer in use.
25 Ιουν 2024 · Lenacapavir is currently approved to treat existing HIV infections. Doctors say the findings can make a big difference in HIV prevention. More than 35,000 people are newly diagnosed with human immunodeficiency virus (HIV) in the U.S. each year, but there are medications to lower the risk of contracting the serious disease.
17 Απρ 2024 · New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
23 Δεκ 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS
14 Ιουλ 2020 · [On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
In February 2019, a commitment was made to end the HIV epidemic in the US with goals of reducing the 40 000 new infections per year by 75% within 5 years and by 90% within 10 years. 97 Clinicians around the world can contribute to ending the HIV epidemic by routinely testing for HIV in clinical settings, rapidly linking persons with HIV to care ...
